Identifying Patients With Unrecognized Treatable Diabetic Macular Edema

A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)

NCT02103283 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

NCT06984822 ·Status: RECRUITING ·Phase: NA

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

NCT00799227 ·Status: COMPLETED ·Phase: PHASE2

Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

NCT00536692 ·Status: COMPLETED ·Phase: PHASE2

Describing Patient With DME, Their Patient Journey and Disease Progression

NCT05966753 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema（DME）

NCT06908876 ·Status: RECRUITING ·Phase: PHASE2

Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema

NCT02732951 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

NCT03590444 ·Status: COMPLETED ·Phase: PHASE4

Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema

NCT05759884 ·Status: UNKNOWN ·Phase: NA

A Study of Avoralstat In Participants With Diabetic Macular Edema

NCT07228559 ·Status: TERMINATED ·Phase: PHASE1

Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema

NCT02088229 ·Status: COMPLETED

Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies

NCT00779142 ·Status: TERMINATED ·Phase: NA

A Single Ascending Dose Cohort Study of AG-73305 in DME Patients

NCT05301751 ·Status: COMPLETED ·Phase: PHASE2

Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)

NCT01947881 ·Status: COMPLETED

A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema

NCT00168389 ·Status: COMPLETED ·Phase: PHASE3

The Course of Response to Focal Photocoagulation for DME

NCT00442156 ·Status: COMPLETED

Evaluation of Tonabersat for DME

NCT05727891 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

NCT04292912 ·Status: TERMINATED ·Phase: PHASE1

OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVO

NCT06332690 ·Status: RECRUITING

A Phase 2a Study to Evaluate the Safety, Tolerability, and Efficacy of SNP318 in DME Patients

NCT07199777 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification

NCT03832179 ·Status: COMPLETED ·Phase: PHASE4

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

NCT05990829 ·Status: UNKNOWN ·Phase: PHASE4

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

NCT00457470 ·Status: WITHDRAWN ·Phase: PHASE2

Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular Edema

NCT03583242 ·Status: UNKNOWN

Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement

NCT01783886 ·Status: COMPLETED ·Phase: PHASE3